Netcare Limited · JSE:NTC

Netcare — Investor Day (June 2018)

26 slides from Netcare's investor day presentation, June 2018

  1. Slide 1: Investor Day

    Investor Day June 2018 Date Presentation name

  2. Slide 2: Agenda

    Agenda • Mental healthcare market • Akeso’s journey • Unique treatment programmes • Management team • Funders • Akeso facilities Date

  3. Slide 3: Mental healthcare market

    Mental healthcare market Date

  4. Slide 4: Market overview – inpatient psychiatry

    Market overview – inpatient psychiatry • Depression is the leading cause of ill health and disability worldwide. According to the latest estimates from WHO, more than 300 million people are now living with depression, an increase of more than 18% between 2005 and 2015 • On average, just 3% of govern

  5. Slide 5: Mental healthcare market

    Mental healthcare market • Within psychiatric treatment, regulatory and funding requirements also distinguish between different types of psychiatric treatment Acute Hospital (57/58) Behavioural* Hospitals Public Sector eg. Tara, Esidemeni and NGO’s (55) Weskoppies etc * Psychiatric and addiction hos

  6. Slide 6: Acute vs mental health hospital: differentiated product offering

    Acute vs mental health hospital: differentiated product offering

  7. Slide 7: Acute vs mental healthcare hospitals: differentiated product offering

    Acute vs mental healthcare hospitals: differentiated product offering A week in the life of a dual diagnosis patient (Addiction plus psychiatric)

  8. Slide 8: Netcare and Akeso psychiatric offering

    Netcare and Akeso psychiatric offering Akeso Randburg Netcare Bell Street Netcare Krugersdorp Netcare Akasia Akeso Parktown Netcare Jakaranda Netcare Linksfield Netcare Garden City Netcare Linmed Akeso Milnerton Akeso Alberton Netcare Rand Netcare Mulbarton Akeso Kenilworth Netcare Vaalpark Akeso Ge

  9. Slide 9: Akeso market share

    Akeso market share Psychiatric beds Psychiatric & Psychiatrists Private funder addiction beds market 28% 21% 40%1 30%2 2 472 beds 3 697 beds 480 Drs R1bn 1. South African Society of Psychiatrists 2. Council for Medical Schemes to December 2016 vs Akeso February 2017

  10. Slide 10: Akeso’s journey

    Akeso’s journey Date Presentation name

  11. Slide 11: Akeso’s history and value proposition

    Akeso’s history and value proposition Total number of beds 928 872 Arcadia - 2018 811 741 2017 - Nelspruit Umhlanga - 2016 654 2016 - George 529 Milnerton - 2015 404 432 2015 - Montrose Manor Stepping Stones -2013 290 2013 - Kenilworth Clinic 218 Parktown - 2012 2011 - Alberton 85 Pietermaritzburg -

  12. Slide 12: Akeso’s history and value proposition

    Akeso’s history and value proposition Bulk of Akeso’s network is Arcadia - 2018 2017 - Nelspruit greenfield builds Umhlanga - 2016 2016 - George Milnerton - 2015 2015 - Montrose Manor +/- 20% capacity added in 2017/18 Stepping Stones -2013 2013 - Kenilworth Clinic Parktown - 2012 2011 - Alberton Pie

  13. Slide 13: Unique treatment programmes

    Unique treatment programmes Date Presentation name

  14. Slide 14: Akeso unique offering: Our major objectives

    Akeso unique offering : Our major objectives To work together and continuously improve our services that keep those people we care for well in their everyday lives To achieve (and measure) the outcomes that matter to individuals and their families/formal and informal support structures To acknowledg

  15. Slide 15: Integrated model of care

    Integrated model of care • Multi-disciplinary healthcare team made up of a variety of allied professionals specifically occupational therapists and clinical psychologists with the support of social workers, art, music and dance therapists, addiction counsellors, biokineticists, somatic experiencing

  16. Slide 16: Our Treatment Units

    Our Treatment Units • General psychiatry • Dual diagnosis • Adolescents • Geriatrics • Eating disorders • High care/special observation • Post natal depression • Under 12 years • Outpatient programmes: • TAG (Akeso graduates) • YAG (young Akeso graduates)

  17. Slide 17: Patient streams

    Patient streams • High functioning (blue) • Medium functioning (orange/green) • Low functioning (red) • Patients can and do move between units and streams

  18. Slide 18: Types of therapy

    Types of therapy Mostly group based Individual therapy in Family or conjoint therapy (6 group sessions per day specialised units offered)

  19. Slide 19: Models of therapy

    Models of therapy • Our basic framework is Dialectical Behaviour Therapy • Evidence and skills based ie. to teach people skills to regulate their nervous systems • Focus on both acceptance and change equally • Reduces self-harming behaviours and reinforces life-affirming behaviours (the end goal is

  20. Slide 20: Management team

    Management team Date Presentation name

  21. Slide 21: Executive

    Executive • Allan Sweidan is the co-founder of Akeso and the current Managing Director. Allan has been with the group since 2004 • Magriet Holder is the Group Clinical Officer . Magriet has been with the Akeso group since 2011 • Sandy Lewis is Group Head of Therapy Services, and has been with the gr

  22. Slide 22: Funders

    Funders Date Presentation name

  23. Slide 23: Medical scheme perspective on psychiatric inpatient funding

    Medical scheme perspective on psychiatric inpatient funding • Schemes, regardless of plan, provide up to 21 days of inpatient care per annum for mental illnesses for their members. • There are 11 separate Prescribed Minimum Benefit categories for acute psychiatric conditions, each with its own set o

  24. Slide 24: Medical scheme perspective on psychiatric inpatient funding – hospital networks

    Medical scheme perspective on psychiatric inpatient funding – psychiatric hospital networks • Psychiatric networks have been introduced since 2017 • A few schemes (e.g. Fedhealth and Discovery) have very recently introduced separate networks of psychiatric facilities • Most schemes (e.g. GEMS, Old M

  25. Slide 25: Annexure

    Annexure Date Presentation name

  26. Slide 26: Market size – NHI potential opportunity

    Market size – NHI potential opportunity • NHI first phase priority: cost of implementation Year 1 Year 2 Year 3 Year 4 Mother and woman – pregnancy 5 668 836 834 5 697 181 069 5 725 666 974 5 754 295 309 Mother and woman – breast cancer 4 845 749 609 5 854 456 429 6 888 155 297 7 017 520 185 Mother

Netcare — Investor Day (June 2018) on 6ix